Disease-free survival following high dose or standard dose therapy in patients with amyloidosis

Files
Kiel-2015-Disease-free.pdf (100.57 KB)
Date
2015
Authors
Kiel, Patrick J.
Trueg, Anne O.
Ferguson, Meagan
Benson, Merrill
Abonour, Rafat
Language
English
Embargo Lift Date
Department
Department of Medicine, IU School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Wiley
Can't use the file because of accessibility barriers? Contact us with the title of the item, permanent link, and specifics of your accommodation need.
Abstract
Description
Keywords
bortezomib, melphalan, autologous haematopoietic cell rescue, treatment related mortality
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kiel, P. J., Trueg, A. O., Ferguson, M., Benson, M., & Abonour, R. (2015). Disease-free survival following high dose or standard dose therapy in patients with amyloidosis. British Journal of Haematology. http://doi.org/10.1111/bjh.13656
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
British Journal of Haematology
Rights
Publisher Policy
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/9106
DOI
https://doi.org/10.1111/bjh.13656
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles
Department of Medicine Works